COMMUNIQUÉS West-GlobeNewswire

-
XTL To Aquire The Social Proxy
20/03/2024 -
Dr. Zeke Unveils Breakthrough Scoliosis Treatment, Transforming Lives in Austin, TX
20/03/2024 -
Immix Biopharma Announces Major Comprehensive Cancer Center as Lead Site for NXC-201 AL Amyloidosis Clinical Trial
20/03/2024 -
Nurix Presents the Discovery and Chemical Structure of First-in-Class CBL-B Inhibitor NX-1607 at the American Chemical Society (ACS) Meeting
20/03/2024 -
AIM ImmunoTech Announces Release of the Next CEO Corner Segment
20/03/2024 -
Celularity Submits Request to U.S. FDA for Orphan Drug Designation for PDA-002 Asset Treating Facioscapulohumeral Muscular Dystrophy
20/03/2024 -
TFF Pharmaceuticals Announces Update on Clinical Programs
20/03/2024 -
Beyond Air® Announces Pricing of $16.0 Million Registered Direct Offering of Common Stock and Warrants
20/03/2024 -
Eko2o S.A.S., a Majority-Controlled Subsidiary of MedCana/SFWJ, Sets Sights on Expansion Into Costa Rica and Central America
20/03/2024 -
RespireRx Pharmaceuticals Inc. Reports Publication of Preclinical Research Results Demonstrating the Ability of CX1739, its Lead Clinical AMPAkine, to Improve Bladder Function After Spinal Cord Injury
20/03/2024 -
Safety Shot, Inc. (Nasdaq: SHOT) Announces Strategic Partnership with Launch 33 Brands to Expand Distribution in Los Angeles
20/03/2024 -
Kane Biotech Extends Exclusivity Period on its Offer for its Interest in STEM Animal Health
20/03/2024 -
Barinthus Bio Reports Full Year 2023 Financial Results and Update on Corporate Developments
20/03/2024 -
Femasys Announces Positive Topline Data from Pivotal Trial for its FDA-Cleared FemaSeed® for the Treatment of Infertility
20/03/2024 -
Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Friday, March 22, 2024
20/03/2024 -
Autonomix (NASDAQ: AMIX) to Present at the Benzinga Virtual Healthcare Summit 2024
20/03/2024 -
Genece Health Announces New Performance Data to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024
20/03/2024 -
Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
20/03/2024 -
PDS Biotechnology Announces Conference Call and Webcast for Business Update and Full Year 2023 Financial Results
20/03/2024
Pages